These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37875214)

  • 1. Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors.
    Sadowska-Klasa A; Dukat-Mazurek A; Zielińska H; Dębska-Zielkowska J; Piekarska A; Moszkowska G; Mensah-Glanowska P; Zaucha JM
    Transplant Cell Ther; 2024 Jan; 30(1):99.e1-99.e10. PubMed ID: 37875214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
    Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
    Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.
    Shayani S; Palmer J; Stiller T; Liu X; Thomas SH; Khuu T; Parker PM; Khaled SK; Forman SJ; Nakamura R
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):298-304. PubMed ID: 23078784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT.
    Elfeky R; Lucchini G; Lum SH; Ottaviano G; Builes N; Nademi Z; Battersby A; Flood T; Owens S; Cant AJ; Young H; Greener S; Walsh P; Kavanagh D; Annavarapu S; Rao K; Amrolia P; Chiesa R; Worth A; Booth C; Skinner R; Doncheva B; Standing J; Gennery AR; Qasim W; Slatter M; Veys P
    Blood Adv; 2020 Jun; 4(11):2418-2429. PubMed ID: 32492158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation.
    Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM
    Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-A secondary CIBMTR analysis.
    Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM
    Br J Haematol; 2024 Jul; 205(1):243-255. PubMed ID: 38817006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
    Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
    Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.
    Schoettler M; Lehmann LE; Margossian S; Lee M; Kean LS; Kao PC; Ma C; Duncan CN
    Blood Adv; 2020 Jun; 4(11):2536-2547. PubMed ID: 32516415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation.
    Pidala J; Tomblyn M; Nishihori T; Ayala E; Field T; Fernandez H; Perez L; Locke F; Alsina M; Ochoa JL; Perkins J; Tate C; Shapiro J; Conwell M; Bookout R; Anasetti C
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1237-44. PubMed ID: 21215811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
    Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
    Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.
    Rangarajan HG; Pereira MSF; Brazauskas R; St Martin A; Kussman A; Elmas E; Verneris MR; Gadalla SM; Marsh SGE; Paczesny S; Spellman SR; Lee SJ; Lee DA
    Transplant Cell Ther; 2021 Nov; 27(11):926.e1-926.e10. PubMed ID: 34407489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
    Labrador J; López-Corral L; López-Godino O; Vázquez L; Cabrero-Calvo M; Pérez-López R; Díez-Campelo M; Sánchez-Guijo F; Pérez-López E; Guerrero C; Alberca I; Del Cañizo MC; Pérez-Simón JA; González-Porras JR; Caballero D
    Bone Marrow Transplant; 2014 May; 49(5):684-90. PubMed ID: 24566710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.
    Nakamae H; Storer BE; Storb R; Storek J; Chauncey TR; Pulsipher MA; Petersen FB; Wade JC; Maris MB; Bruno B; Panse J; Petersdorf E; Woolfrey A; Maloney DG; Sandmaier BM
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):384-94. PubMed ID: 19900571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.